GR3033729T3 - Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides - Google Patents

Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides

Info

Publication number
GR3033729T3
GR3033729T3 GR20000401423T GR20000401423T GR3033729T3 GR 3033729 T3 GR3033729 T3 GR 3033729T3 GR 20000401423 T GR20000401423 T GR 20000401423T GR 20000401423 T GR20000401423 T GR 20000401423T GR 3033729 T3 GR3033729 T3 GR 3033729T3
Authority
GR
Greece
Prior art keywords
intermediates
prepare
bridged bisindolylmaleimides
bisindolylmaleimides
bridged
Prior art date
Application number
GR20000401423T
Other languages
English (en)
Inventor
Margaret Mary Faul
Christine Ann Krumrich
Leonard Larry Winneroski Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21725638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3033729(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of GR3033729T3 publication Critical patent/GR3033729T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
GR20000401423T 1995-11-20 2000-06-20 Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides GR3033729T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US734595P 1995-11-20 1995-11-20

Publications (1)

Publication Number Publication Date
GR3033729T3 true GR3033729T3 (en) 2000-10-31

Family

ID=21725638

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401423T GR3033729T3 (en) 1995-11-20 2000-06-20 Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides

Country Status (31)

Country Link
EP (1) EP0776899B1 (el)
JP (2) JP4100708B2 (el)
KR (1) KR100342142B1 (el)
CN (1) CN1066734C (el)
AR (2) AR004719A1 (el)
AT (1) ATE191219T1 (el)
AU (1) AU701659B2 (el)
BR (1) BR9611709A (el)
CA (1) CA2237401C (el)
CO (1) CO4750824A1 (el)
CZ (1) CZ150398A3 (el)
DE (1) DE69607443T2 (el)
DK (1) DK0776899T3 (el)
EA (1) EA000639B1 (el)
ES (1) ES2145978T3 (el)
GR (1) GR3033729T3 (el)
HU (1) HU225716B1 (el)
IL (1) IL124415A (el)
MX (1) MX9803791A (el)
MY (1) MY118946A (el)
NO (1) NO310195B1 (el)
NZ (1) NZ323282A (el)
PE (1) PE17998A1 (el)
PL (1) PL184728B1 (el)
PT (1) PT776899E (el)
TR (1) TR199800876T2 (el)
TW (1) TW371661B (el)
UA (1) UA56145C2 (el)
WO (1) WO1997019080A1 (el)
YU (1) YU49316B (el)
ZA (1) ZA969645B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2245029A1 (en) 1998-03-13 1999-09-13 University Of British Columbia Granulatimide compounds as g2 checkpoint inhibitors
AU758241B2 (en) * 1998-03-13 2003-03-20 University Of British Columbia, The Granulatimide derivatives for use in cancer treatment
US6127401A (en) 1998-06-05 2000-10-03 Cephalon, Inc. Bridged indenopyrrolocarbazoles
US6300106B1 (en) 2000-11-22 2001-10-09 Ppg Industries Ohio, Inc. Method of preparing 3-[2-{(Methylsulfonyl)oxy}-ethoxy ]-4-(triphenylmethoxy)-1-butanol, methane sulfonate
EP2181999A1 (en) 2008-11-03 2010-05-05 Zentiva, A.S. Method of manufacturing ruboxistarin
WO2023192984A1 (en) * 2022-03-31 2023-10-05 4M Therapeutics Inc. N-desmethyl ruboxistaurin as kinase inhibitor
WO2024159211A1 (en) * 2023-01-27 2024-08-02 Mellicell, Inc. Methods and compositions for treatment of obesity and diseases associated with fat cell enlargement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
CA2137203C (en) * 1993-12-07 2006-11-28 William Francis Heath Jr. Protein kinase c inhibitors
US5559228A (en) * 1995-03-30 1996-09-24 Eli Lilly And Company Synthesis of bisindolylmaleimides

Also Published As

Publication number Publication date
JP4100708B2 (ja) 2008-06-11
IL124415A (en) 2003-11-23
ZA969645B (en) 1998-05-18
CN1207740A (zh) 1999-02-10
PT776899E (pt) 2000-08-31
CO4750824A1 (es) 1999-03-31
ATE191219T1 (de) 2000-04-15
MX9803791A (es) 1998-09-30
NZ323282A (en) 1999-01-28
AR004718A1 (es) 1999-03-10
EA199800368A1 (ru) 1998-12-24
UA56145C2 (uk) 2003-05-15
WO1997019080A1 (en) 1997-05-29
BR9611709A (pt) 1999-02-23
PL184728B1 (pl) 2002-12-31
NO982105L (no) 1998-05-08
ES2145978T3 (es) 2000-07-16
CA2237401C (en) 2003-10-21
JP2008138006A (ja) 2008-06-19
MY118946A (en) 2005-02-28
YU61096A (sh) 1999-03-04
CZ150398A3 (cs) 1998-12-16
EA000639B1 (ru) 1999-12-29
NO982105D0 (no) 1998-05-08
AU7738896A (en) 1997-06-11
EP0776899B1 (en) 2000-03-29
KR19990067600A (ko) 1999-08-25
KR100342142B1 (ko) 2002-08-22
DE69607443D1 (de) 2000-05-04
CN1066734C (zh) 2001-06-06
YU49316B (sh) 2005-06-10
CA2237401A1 (en) 1997-05-29
JP2000500496A (ja) 2000-01-18
DE69607443T2 (de) 2000-08-10
EP0776899A1 (en) 1997-06-04
HUP9901975A2 (hu) 1999-11-29
DK0776899T3 (da) 2000-07-10
IL124415A0 (en) 1998-12-06
NO310195B1 (no) 2001-06-05
AU701659B2 (en) 1999-02-04
TW371661B (en) 1999-10-11
HU225716B1 (en) 2007-07-30
PL326753A1 (en) 1998-10-26
TR199800876T2 (xx) 1998-08-21
HUP9901975A3 (en) 2000-01-28
AR004719A1 (es) 1999-03-10
PE17998A1 (es) 1998-04-20

Similar Documents

Publication Publication Date Title
IL116770A0 (en) 2, 8-disubstituted quinazolinones their preparation and use
IL118469A (en) Naphthalene derivatives their preparation and intermediates thereof
IL116325A0 (en) Substituted 1h-imidazoles their preparation and use
IL118825A0 (en) 6-dimethylaminomethyl -1- phenyl-cyclohexane compounds their preparation and use
IL119864A0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use
AP9801265A0 (en) Novel 5-amino-3-cyano-4-ethylsulfinyl-1-phenyl-pyrazole compounds and their use as pesticides
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
SI1019358T1 (en) 3,3-diarylpropylamines , their use and preparation
HUP9801910A3 (en) Dolastatin derivatives, their preparation and use
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
GB9516943D0 (en) Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
GB9500856D0 (en) Composition and use
GR3033729T3 (en) Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
HUP9600730A1 (en) 1,4-tetrazolinone-derivatives and use thereof as herbicides
IL116001A0 (en) Alkoxyimino-acetimidates and their use as pesticides
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
IL118444A0 (en) Mercapto-triazolyl-silanes their preparation and use
IL122686A0 (en) Benzylhydroxylamines their preparation and use
EP0786248A3 (fr) Utilisation du dithioacétate de S,S'-éthylidène à titre d'ingrédient parfumant et aromatisant
ZA961972B (en) 3-Aryluracils and intermediates for their preparation.
IL115980A0 (en) 2-[4 biphenyloxymethylene] anilides, their preparation and use
IL119362A0 (en) Disposable hairdresser's set

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees